Phase I trial of pegylated liposomal doxorubicin and lapatinib in the treatment of metastatic breast cancer (MBC): Final results.
Mary E. Cianfrocca
Research Funding - GlaxoSmithKline
Virginia G. Kaklamani
No relevant relationships to disclose
Steven T. Rosen
No relevant relationships to disclose
Jamie H. Von Roenn
No relevant relationships to disclose
Alfred Rademaker
No relevant relationships to disclose
Deborah A. Smith
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Stephen D. Rubin
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Caitlin Meservey
No relevant relationships to disclose
Regina Uthe
Consultant or Advisory Role - GlaxoSmithKline
William John Gradishar
Consultant or Advisory Role - GlaxoSmithKline